Trials / Completed
CompletedNCT05485051
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
Impact of Chlorhexidine Bath on Healthcare-associated Infections Acquisitions in Intensive Care Units - A Cluster Randomized Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 15,730 (actual)
- Sponsor
- Hospital do Coracao · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cluster randomized controlled trial comparing two bathing strategies in critically ill patients. The intervention group will receive daily bathing with chlorhexidine. The control group will receive usual care.
Detailed description
Healthcare-associated infections (HAI) are common complications in critically ill patients and are associated with increased costs, higher length of stay, and higher morbimortality. Data shows that daily chlorhexidine baths might be associated with lower HAI rates in a broad population of critically ill patients. The purpose of this trial is to evaluate the effect of daily bathing with chlorhexidine compared to usual baths (soap and water) on HAI in critically ill patients.
Conditions
- Health Care Associated Infection
- Ventilator Associated Pneumonia
- Central Line-associated Bloodstream Infection (CLABSI)
- Catheter-Associated Urinary Tract Infection
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 2% chlorhexidine digluconate solution with surface-active agents | Bathing will be performed at least daily using 2% chlorhexidine digluconate solution with surface-active agents on all applicable bathing surfaces, which consists of the entire body surface of the patient except eyes, inner ear, oral mucosa, and areas of loss of skin continuity (such as burnt areas, pressure injuries, etc.); These areas will be bathed according to each center current practice. |
| OTHER | Usual Baths | Bathing will be performed at least daily using soap and water (performed according to the current practice in each center) on all applicable bathing surfaces, which consists of the entire body surface of the patient except eyes, inner ear, oral mucosa, and areas of loss of skin continuity (such as burnt areas, pressure injuries, etc.); These areas will be bathed according to each center current practice. |
Timeline
- Start date
- 2022-08-03
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
- First posted
- 2022-08-02
- Last updated
- 2024-06-13
Locations
16 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05485051. Inclusion in this directory is not an endorsement.